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Edited by Peter BrzezinskiAbstract Mutations in the ATP-binding cassette (ABC) pro-
teins ABCG5 or ABCG8 cause sitosterolemia, a condition with
increased accumulation of plant sterols. Upon high level expres-
sion of the ABCG5 and ABCG8 proteins in baculovirus-Sf9 cell
expression system we found a distinct, vanadate sensitive ATP-
ase activity in isolated membrane preparations only when the
two proteins were co-expressed. This ATPase activity was signif-
icantly stimulated by the addition of certain androgen hormones
and analogs, and was eﬀectively inhibited by progesterone. Our
results provide a new aspect of biochemical and functional char-
acterization of the ABCG5/ABCG8 proteins and their possible
involvement in steroid hormone transport or regulation.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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cassette transporters1. Introduction
Sitosterolemia (also known as phytosterolemia, OMIM
210250) is a rare heritable disorder of lipid metabolism. It
was shown that mutations in either one of the ABC-trans-
porter genes, coding for proteins ABCG5 and ABCG8, respec-
tively, are responsible for the development of this disease [1,2].
Sitosterolemia patients suﬀer from premature coronary artery
disease and atherosclerosis, and the diagnosis of sitosterolemia
is based on high level of plant and shellﬁsh sterols in the blood
plasma, which is the result of increased intestinal absorption
and decreased biliary excretion of these compounds.
ABCG5 and ABCG8 are ATP-binding cassette (ABC) type
proteins, belonging to the ABCG subfamily. In humans this
subfamily of proteins includes ﬁve members, ABCG1,
ABCG2, ABCG4, ABCG5 and ABCG8. These proteins have
a unique domain structure, consisting of one single nucleotideAbbreviations: ABC, ATP binding cassette; DHEA, dehydroepiand-
rosterone; GST, glutathione-S-transferase; SLA, 3-doxyl-17b-hydro-
xy-5a-androstane; RAMEB, random methylated b-cyclodextrin
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doi:10.1016/j.febslet.2006.10.012binding domain (NBD) located N-terminally from the six-helix
transmembrane domain (TMD) (Fig. 1). According to our cur-
rent knowledge, these ‘‘ABC half-transporters’’ have to homo-
or heterodimerize in order to form functionally active trans-
porters. In sitosterolemia patients either the ABCG5 or the
ABCG8 gene was found to be mutated, indicating that both
half-transporters are necessary for normal function. This ge-
netic background suggests that these proteins, at least for sito-
sterol transport, may function as obligate heterodimers. Both
ABCG5 and ABCG8 are expressed in the liver and in the intes-
tine, and co-localize in the apical membranes of polarized cells
[3,4]. In cell culture experiments it has been shown that the
expression of both ABCG5 and ABCG8 is required for either
of them to reach the cell surface, while the other members of
the ABCG family were excluded from playing a role in target-
ing either ABCG5 or ABCG8 to the plasma membrane [5].
In order to perform a detailed biochemical analysis of the
human ABCG5/ABCG8, we have expressed these proteins in
the heterologous Sf9 insect cell system. These cells have been
repeatedly used to characterize human transporters as,
although underglycosylated, all these proteins were found to
reserve their proper structure and function [6,7]. Moreover, a
large number of possible substrates and modulators can be
screened by measuring the ATPase activity of functionally ac-
tive ABC transporters. Recently, Wang et al. [8] reported the
successful expression of mouse Abcg5 and Abcg8 and the co-
expression of the two proteins in insect cells. They found the
two half-transporters to form a heterodimer and demonstrated
that the Abcg5/g8 heterodimer can hydrolyze ATP and trans-
fer sterols from liposomes to inside out vesicles prepared from
Sf9 cells, expressing the heterodimer transporter.
In the present work we have performed co-expression of
human ABCG5 and ABCG8 and found that this co-expression
yielded a speciﬁc, vanadate-sensitive ATPase activity, which
was signiﬁcantly stimulated by certain androgens and related
compounds, while inhibited by progesterone. These data indi-
cate a hitherto unexpected function of the human ABCG5/
ABCG8 proteins with a possible physiological relevance.2. Materials and methods
4-Androstene 3,17 dione, dehydroepiandrosterone (DHEA), 3-dox-
yl-17b-hydroxy-5a-androstane (SLA, Aldrich cat number: 253545)blished by Elsevier B.V. All rights reserved.
Fig. 1. Membrane topology of ABCG5 and ABCG8. The membrane
topology model of human ABCG5 and ABCG8 shown is based on the
model of human ABCG2 [20]. The location of the ABCG5 Walker A
mutation studied in the present work is indicated with an arrow.
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ylated b-cyclodextrin (RAMEB)-cyclodextrin loaded with cholesterol
or with b-sitosterol was from Cyclolab (Budapest). Anti-ABCG8 poly-
clonal antibody was from NOVUS.
2.1. Generation of human ABCG5 and ABCG8 cDNAs and expression in
Sf9 insect cells
cDNAs of human ABCG5 and ABCG8 were cloned after PCR
ampliﬁcation from a human fetal liver cDNA library and were se-
quence conﬁrmed [9]. Full-length cDNAs were inserted into a baculo-
virus transfer vector (pAcUW21, Invitrogen), Sf9 insect cells were
cultured and infected with the recombinant baculoviruses as described
[10].
2.2. Membrane preparation and Western blotting
Virus-infected Sf9 cells were harvested, cell membranes were iso-
lated, and membrane protein concentrations were determined as de-
scribed previously [11]. The expression level of human ABCG5 and
ABCG8 was 2–4% of total membrane proteins as determined by den-
sitometry of Coomassie-stained gels. The Sf9 membrane preparations
contained both plasma membrane and intracellular membrane mate-
rial. ATPase activity of each membrane preparation was determined
and the preparation with highest activity was used for functional stud-
ies. (As the titer of the ABCG5- and ABCG8-viral supernatants varied,
the ‘optimal’ ratio was not the same at each coexpression experiment.)
For comparative activity assays membrane preparations with compa-
rable amounts of the protein variants were used.
The level of ABCG5 and ABCG8 expression was detected by immu-
noblotting using speciﬁc polyclonal antibodies. Since an anti-human
ABCG5 antibody was not commercially available, in order to generate
such an antibody we fused the ABC domain of ABCG5 (aa 1–381) to
glutathione-S-transferase (GST), the fusion protein was expressed in
E. coli, and the inclusion bodies, which contained the fusion protein,
were subjected to SDS–PAGE. The band of the fusion protein was
cut out and used to immunize mice. Antisera of the immunized mice
were used without puriﬁcation. Protein–antibody interactions on Wes-
tern blots were detected by using the enhanced chemiluminescence
technique (ECL, Amersham Biosciences). The quantitative level of
protein expression was determined by densitometry of the immuno-
blots.
2.3. Assay of vanadate-sensitive ATPase activity
ATPase activity in the well characterized membrane preparations
was measured according to the procedure described earlier [6]. The
total protein content of the membrane preparations was determined
and used for normalization of the ATPase activity. All activity mea-
surements were carried out in at least two independent membrane
preparations, in triplicates.Fig. 2. Expression of human ABCG5 and ABCG8 and the ABCG5
Walker A mutant variant in Sf9 insect cells. Aliquots of 20 lg of
membrane protein were subjected to gel electrophoresis and immuno-
blotting using anti-ABCG5 polyclonal antibody described in this
report, and anti-ABCG8 polyclonal antibody, as indicated above the
immunoblots.3. Results
In order to study the functional properties of both normal
and a mutant form of the human ABCG5 and ABCG8 trans-
porters, we expressed these proteins in Sf9 insect cells, bothindividually and in combination. The proposed membrane
topology of human ABCG5 and ABCG8 is shown in Fig. 1.
Co-expression of the wtABCG5 and wtABCG8 as well as
K92M-ABCG5 and wtABCG8 was carried out by using diﬀer-
ent ratios of the corresponding recombinant baculovirus
supernatants. The level of ABCG5 and ABCG8 expression
was detected by immunoblotting, using polyclonal antibodies.
Since an anti-ABCG5 antibody was not commercially avail-
able, in order to generate such an antibody we fused the
ABC domain of ABCG5 (aa 1–381) to GST, expressed the fu-
sion protein in E. coli, and used this protein to immunize mice.
This approach yielded an antibody selectively recognizing
ABCG5 but not reacting with ABCG8 (see Fig. 2). In indepen-
dent experiments we have tested that the antibodies applied
did not cross-react with any of the proteins in the ABCG fam-
ily (ABCG1, ABCG2 and ABCG4, data not shown).
Fig. 2 demonstrates that the expression levels of the wild
type as well as those of the corresponding mutant variant
was comparable. The apparent molecular mass for both of
the ABCG5 and ABCG8 proteins corresponded to the under-
glycosylated forms, when compared to those expressed in
mammalian cells (data not shown). Interestingly, when
ABCG5 was expressed individually, a doublet of immuno-
reactive bands was observed, with a variable ratio of the bands
in diﬀerent membrane preparations. However, when ABCG5
and ABCG8 were co-expressed, ABCG5 always appeared as
a single immuno-reactive band, corresponding to the faster
moving band of the doublet. A possible explanation of this
observation is that in the absence of ABCG8 a fraction of
the maturing ABCG5 can not fold and/or can not be correctly
inserted into the membrane. Such a folding diﬀerence may trig-
ger unusual migration behaviour on SDS–PAGE, probably
due to strong internal hydrophobic interactions preserved even
in the presence of the detergent.
In order to study the catalytic activity of the wt ABCG5 and
ABCG8 and their mutant variant, we determined their vana-
date sensitive ATPase activity in isolated Sf9 cell membrane
M. Mu¨ller et al. / FEBS Letters 580 (2006) 6139–6144 6141preparations. We have explored this ATPase activity by using
variable expression levels of the two proteins, both in individ-
ual and co-expression studies, as described in Section 2. When
the mutant variant of the ABCG5 transporter was expressed,
we established a system to produce membranes containing
comparable amounts of the diﬀerent proteins (see Fig. 2).Fig. 3. Androstan stimulated, vanadate-sensitive ATPase activity of human A
activity of isolated Sf9 membranes was determined by measuring the rate
MgATP, as described in Section 2. Data points indicate the means ± S.D. va
membrane preparations. (A) The stimulatory eﬀect of 5 lM SLA and the inhi
on ABCG8 and on the ABCG5/G8 heterodimer. The ATPase activities of
ATPase activity) are also presented. (B) Concentration-dependence of the stim
of the ABCG5/ABCG8 heterodimer. SLA: 3-doxyl-17b-hydroxy-5a-andro
3,17dione.As shown in Fig. 3A, the vanadate-sensitive ATPase activity
in membranes expressing ABCG5 individually did not signiﬁ-
cantly exceed the activity measured in the control, b-galactosi-
dase expressing membranes. The expression of ABCG8 also
resulted in a variable, low-level ATPase activity, while the
co-expression of ABCG5 and ABCG8 did not trigger aBCG5 and ABCG8 expressed individually or as heterodimers. ATPase
of vanadate sensitive inorganic phosphate liberation, using 3.3 mM
lues of at least three measurements, performed in two or three diﬀerent
bitory eﬀect of 50 lM progesterone on the ATPase activity of ABCG5,
the membranes of Sf9 cells expressing b-galactosidase (background
ulatory eﬀect of diﬀerent androstan derivatives on the ATPase activity
stan; DHEA: dehydroepiandrosterone; 4A-3,17dione: 4-androstene
6142 M. Mu¨ller et al. / FEBS Letters 580 (2006) 6139–6144signiﬁcantly higher membrane ATPase activity than the sum of
those generated by ABCG5 and ABCG8 (5–7 nmol/mg mem-
brane protein/min), over the control level.
It is well documented that compounds transported by a gi-
ven ABC transporter may signiﬁcantly stimulate the rate of
ATP hydrolysis performed by the protein. In order to identify
such transported or modulator substrates for ABCG5 and
ABCG8, we have measured the ATPase activity of the mem-
branes containing these proteins, and tested various expression
levels as well as a great number of potential interacting com-
pounds (see Table 1). None of these compounds had any sig-
niﬁcant eﬀect on the rate of ATP-hydrolysis in membranes
containing individually either ABCG5, or ABCG8 (not
shown). Most of these compounds were also inactive when
examined in membranes containing the co-expressed ABCG5
and ABCG8 proteins. However, we found that when certain
androstan derivatives, namely 4-androstene 3,17dione, DHEA
or 3-doxyl 17b-hydroxy-5a-androstane (SLA, carrying a spin
label) were added to the ATPase assay (initially tested in a con-
centration of 5 lM), a pronounced increase in the ATPase
activity of the co-expressed ABCG5/ABCG8, while not in
the membranes containing ABCG5 or ABCG8 alone, was ob-
served (Fig. 3A).
As shown in Fig. 3A, the increase in membrane ATPase
activity by SLA (up to 25 nmol/mg membrane protein/min)
represented a 3–5-fold stimulation of the basal ATPase activity
in the presence of co-expressed ABCG5/ABCG8, measured
above the level of b-galactosidase control membranes. By
altering the baculovirus titers during Sf9 cell infection, we pre-
pared ABCG5/ABCG8 containing membranes showing a max-
imum level of androstan-stimulated ATPase activity.
Interestingly, progesterone, at a concentration up to 50 lMTable 1
List of compounds tested in the ATPase activity assay of ABCG5/ABCG8 c
Compound
3-doxyl-17b-hydroxy-5a-Androstane (SLA)
4-Androstene-3,17-dione
Dehydroisoandrosterone, 5-Androsten-3b-ol-17-one (DHEA)
Progesterone, 4-Pregnene-3,20-dione
5a-Dihydrotestosterone (5a-Androstan-17b-ol-3-one)
5a-Androstane
cis-Androsterone, 5a-Androstan-3a-ol-17-one
Dihydroandrosterone (5a-Androstane-3a,17b-diol)
Testosterone (4-Androstene-17b-ol-3-one)
DHEA-3-sulfate
b-Estradiol (1,3,5[10]-Estratriene-3,17b-diol)
Estrone (1,3,5[10]-Estratrien-3-ol-17-one)
b-Sitosterol
Campesterol
Ergosterol
Cholesterol
RAMEB cholesterol complex (5 mM)
RAMEB b-sitosterol complex (5 mM)
6-Methyl-prednisolone
Genistein
Stearic acid
Verapamil
Taurocholate
Tauro-chenodeoxycholate
Rhodamin-123
Hydrocortisone
Prostaglandin E1
Prostaglandin F
For stimulation and inhibition data see also Fig. 3.
aMaximal concentration upon complete release of complexed lipid.did not stimulate ABCG5/ABCG8 ATPase, while it showed
a nearly complete inhibition of the SLA-triggered ATPase
activity of the ABCG5/ABCG8 proteins (see Fig. 3A). As a
negative control, we used the co-expression of a Walker A mu-
tant (ABCG5-K92M) of ABCG5 with the wild-type ABCG8
(G5K92M/G8). This mutant combination has been shown ear-
lier not to possess any ATP hydrolyzing or cholesterol transfer
activity [4,8]. As expected, the mutation caused a complete loss
of the androstan-stimulated ATPase activity of the complex.
Fig. 3A presents the data for 5 lM SLA, but the same was true
in the presence of 4-androstene 3,17dione, or DHEA (5 lM
each, not shown).
In the following experiments we have studied the ATP-
dependence and androstan concentration dependence of the
ABCG5/ABCG8 ATPase activity. Similar to other ABCG
type ATPases, the ABCG5/ABCG8 ATPase activity was max-
imum at 5 mM ATP, and the apparent Km for ATP was
around 0.5 mM (data not shown).
Fig. 3B demonstrates the concentration-dependence of the
speciﬁc stimulation of ABCG5/ABCG8 ATPase activity by
various androstan derivatives. The concentrations needed for
half-maximum stimulation of the ATPase activity of the co-ex-
pressed ABCG5/ABCG8 was in the 1–3 lM range in the case
of each androstan derivative. The highest level of ATPase
stimulation was achieved by the SLA compound, and each
compound caused a somewhat decreased level of ATPase stim-
ulation at concentrations above 10 lM. Based on the pheno-
type of sitosterolemia, cholesterol and sitosterols are likely
the physiological substrates of the heterodimer transporter
complex. However, in the Sf9 cell membrane preparations we
found no eﬀect on the ABCG5/ABCG8 ATPase when either
cholesterol or b-sitosterol was added to the incubation media.o-expressed
Concentration range (lM) Eﬀect
1–100 Stimulation
1–100 Stimulation
1–100 Stimulation
1–300 Inhibition
1–100 No
1–20 No
1–20 No
1–150 No
1–150 No
1–100 No
1–50 No
1–20 No
1–100 No
1–100 No
1–100 No
1–100 No
33a No
25a No
50–300 No
1–20 No
50–300 No
10–50 No
1–20 No
1–20 No
1–100 No
1–100 No
20–200 No
20–200 No
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ious preincubation/loading conditions. We also preincubated
the Sf9 membrane preparations with RAMEB-cyclodextrin
preparations, loaded with cholesterol or with b-sitosterol.
Again, various incubation conditions, resulting in signiﬁcant
cholesterol/sitosterol enrichment of the membrane prepara-
tions, had no signiﬁcant eﬀect on the ATPase activity of
ABCG5/ABCG8 (data not shown). Interestingly, in a recent
paper a slight inhibition of the ABCG5/G8 ATPase activity
caused by cholesterol was reported [8].4. Discussion
In the present study we expressed ABCG5 and ABCG8 indi-
vidually and in combinations in Sf9 cells. The same insect cell
expression system was recently used to provide the ﬁrst in vitro
documentation of ABCG5/G8-driven sterol transfer and ATP-
ase activity [8]. It was also documented by co-immunoprecipa-
tion that co-expressed ABCG5 and ABCG8 form a
heterodimer in the Sf9 membrane preparations [8].
When we studied the speciﬁc, vanadate-sensitive ATPase
activity of the ABCG5/ABCG8 heterodimer in isolated mem-
brane preparations, we found a signiﬁcant stimulation of this
ATPase, but not that of the individually expressed proteins,
by several androstan derivatives. Interestingly, neither the
basal, nor the androstan-stimulated ATPase activity was
aﬀected by many other sterols and steroid hormones, including
corticosteroids and estrogens, while a pronounced inhibition
of the androstan-stimulated ATPase was obtained by low con-
centrations of progesterone. We could also not achieve any
modulation of the ABCG5/ABCG8 ATPase activity by sitos-
terol or cholesterol addition, or by the enrichment of the mem-
branes with these sterols. The speciﬁc, androgen-stimulated
ATPase activity of the ABCG5/ABCG8 heterodimer was abol-
ished when a key lysine was changed to methionine (K92M) in
the Walker A motif of ABCG5.
The stimulating eﬀect by androstans, and the inhibitory ef-
fect by progesterone (all at low micromolar concentrations),
and the lack of eﬀect by corticosteroids and estrogens, suggest
a speciﬁc recognition of selected steroid hormones by the
ABCG5/ABCG8 complex. It has been already reported that
certain ABC transporters may transport steroid hormones or
hormone derivatives. As an example, ABCB1 (MDR1 or
Pgp) is capable of interacting with androstans and with proges-
terone [12–14], but the required concentrations of various
androstans, including those examined in the present report,
were found to be approximately ten times higher than here
in the case of the ABCG5/ABCG8 heterodimer. Furthermore,
the addition of progesterone (between 10 and 50 lM) stimu-
lates, rather than inhibits, the ATPase activity of ABCB1
(Mu¨ller et al, unpublished results). ABCG2 and MRP1, 2
and 3 can transport various hormone derivatives, e.g. sulfated
or glucuronidated estrogens, but free estrogens and androstans
are probably not transported by these proteins [15–17]. In con-
trast, we found that the ABCG5/ABCG8 ATPase was selec-
tively activated by certain andostans, while not aﬀected by
the conjugated steroids.
An apparent limitation of the described in vitro assay for the
ABCG5/ABCG8 transporter is that cholesterol and sitosterol
were ineﬀective in modulating the activity of the transporter.It is possible that diﬀerences in the lipid composition of the
Sf9 cells membranes compared to that in the apical plasma
membranes of mammalian cells, account for this ﬁnding. An-
other possibility may be the necessity of extracellular sterol
acceptors, such as bile salt micelles, for such a modulation. In-
deed, cholesterol transfer by ABCG5/G8 from liposomes to
the Sf9 vesicles was recently demonstrated [8]. The same
authors found that cholesterol had a slight inhibitory, instead
of a stimulatory eﬀect on the ATPase activity of the puriﬁed
ABCG5/G8, reconstituted into proteoliposomes. In another
recent paper the puriﬁcation and ATP hydrolysis of ABCG5/
G8 after Pichia pastoris expression has been reported [18].
Again, no stimulation of the ATPase activity has been ob-
served in the presence of cholesterol or plant sterols.
Nevertheless, the ﬁnding that androgens and progesterone
speciﬁcally interact with these transporters revealed a hitherto
unexpected function of the human ABCG5/ABCG8 proteins,
with a possible physiological relevance. Since xenobiotic and
steroid hormone transport is an important feature of the
blood-testis barrier, and mRNA expression of the human
ABCG5/ABCG8 was found to be substantial in the Sertoli
cells [19], our results raise the possibility of such a role for
ABCG5/ABCG8. The signiﬁcant changes in cholesterol
metabolism and secretion during pregnancy may also be re-
lated to the inhibitory eﬀect of progesterone on the physiolog-
ical sterol extrusion by ABCG5/ABCG8.
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